{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-007527","form_type":"8-K","ticker":"XBIO","cik":"0001534525","company_name":"Xenetic Biosciences, Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.723489+00:00","generated_at":"2026-05-30T07:24:36.723638+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Two Xenetic directors not standing for re-election at 2024 Annual Meeting","bullets":["James E. Callaway and Adam Logal will not stand for re-election at the 2024 Annual Meeting of Stockholders.","Neither director's decision related to any disagreement with the Company on operations, policies or practices.","The Company thanked both directors for their dedicated Board service."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-007527","json":"https://secwatch.observer/filing/0001683168-24-007527.json","markdown":"https://secwatch.observer/filing/0001683168-24-007527.md","text":"https://secwatch.observer/filing/0001683168-24-007527.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/0001683168-24-007527-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/xenetic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:24:36.723638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cde4d12792","claim":"Adam Logal departed as member of the board of directors at Xenetic Biosciences, Inc..","evidence_excerpt":"On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/0001683168-24-007527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"},{"claim_id":"df3269ab98","claim":"James E. Callaway departed as member of the board of directors at Xenetic Biosciences, Inc..","evidence_excerpt":"On October 29, 2024, James E. Callaway and Adam Logal, each a member of the board of directors (the “Board”) of Xenetic Biosciences, Inc. (the “Company”), informed the Company of their intention to not stand for re-election at the Company’s 2024 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534525/000168316824007527/0001683168-24-007527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}